Counterpoint Mutual Funds’s Octave Specialty Group OSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-12,601
Closed -$162K 296
2024
Q2
$162K Buy
+12,601
New +$192K 0.04% 225
2023
Q4
Sell
-10,374
Closed -$125K 115
2023
Q3
$125K Buy
10,374
+1,440
+16% +$19.4K 0.1% 156
2023
Q2
$127K Buy
+8,934
New +$131K 0.12% 107
2023
Q1
Sell
-14,463
Closed -$252K 336
2022
Q4
$252K Buy
14,463
+6,251
+76% +$92.9K 0.27% 23
2022
Q3
$105K Buy
+8,212
New +$109K 0.26% 177

Other funds holding OSG

Counterpoint Mutual Funds's OSG Position: Q3 2024 in Review

Counterpoint Mutual Funds sold out of Octave Specialty Group (OSG) in Q3 2024, closing a stake of 12,601 shares — an estimated $162K sold.

Counterpoint Mutual Funds first reported a position in OSG in Q3 2022 and held it in 5 quarters. The position peaked at $252K in Q4 2022. 180 funds tracked by Wall St. Rank hold OSG as of Q3 2024.

  • Counterpoint Mutual Funds reported no remaining Octave Specialty Group position as of Q3 2024 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 12,601 Octave Specialty Group shares in Q3 2024, an estimated $162K.
  • Counterpoint Mutual Funds first reported a position in Octave Specialty Group in Q3 2022 and held it in 5 quarters.
  • Counterpoint Mutual Funds's Octave Specialty Group position peaked at $252K in Q4 2022.
  • 180 funds tracked by Wall St. Rank held Octave Specialty Group as of Q3 2024.

Based on Counterpoint Mutual Funds's 13F filing for Q3 2024, filed 12 Nov 2024.